A Mahajan, T Vaidya, A Gupta, S Rane… - Cancer Research …, 2019 - journals.lww.com
Introduction: Artificial intelligence (AI) is the fascinating result of the convergence of various technologies, algorithms and approaches. Its role in early detection and diagnosis will be a …
VM Patil, V Noronha, A Joshi… - Cancer Research …, 2019 - journals.lww.com
Checkpoint inhibitors are versatile immunomodulatory agents, and they are being approved for the treatment of an increasing number of cancers, based on the demonstration of clinical …
S Roy, TK Mandal, S Das, S Srinivas… - Cancer Research …, 2020 - journals.lww.com
Background: Head-and-neck cancer (HNC) is one of the most common cancers in India and requires a multidisciplinary approach for disease management. Objectives: We aimed to …
RK Meena, NA Syed, ZA Sheikh, FR Guru… - JCO Global …, 2022 - ascopubs.org
PURPOSE Ovarian cancer (OC) is ranked as the third most common gynecologic cancer in various Indian cancer registries. In India, OC is seen in the younger age group, with a …
MA Al-Ruzzieh, O Ayaad - British Journal of Nursing, 2021 - magonlinelibrary.com
Aim: To examine the impact of emotional intelligence on the effective implementation of a professional practice model in a specialised cancer centre. Methods: The study used a cross …
Abstract A series of novel 1, 2, 3-triazole and chiral Schiff base hybrids 2–6 were synthesized by Schiff base condensation reaction from pre-prepared parent component of …
G Abraham, V Noronha, S Rajappa… - … Journal of Cancer, 2022 - Wiley Online Library
The real‐world data on short course of immune checkpoint inhibitor (ICI) use are sparse and merit exploration. A multicentric observational study on the safety and efficacy of ICI in …
R Verma, L Rao, D Nagpal, M Yadav… - Recent Patents on …, 2024 - ingentaconnect.com
Cancer is a complex, one of the fatal non-communicable diseases, and its treatment has enormous challenges, with variable efficacy of traditional anti-cancer agents. By 2025, it is …
L Bonilla-Vidal, M Świtalska, M Espina, J Wietrzyk… - …, 2024 - Taylor & Francis
Aim: Cancer constitutes the second leading cause of death worldwide, with conventional therapies limited by significant side effects. Melatonin (MEL), a natural compound with …